Entera Bio market cap ENTX
Share price times shares outstanding: what the whole company sells for, since 2019.
- Today, Nov 2, 2026
- $535M
- Highest close in our data
- $559.2M
- Aug 2026
Entera Bio is worth $535M at the close on Nov 2, 2026, at $3.09 a share.
That is up 273% over the last year and up 450% over five years.
Its highest close in our data was $559.2M in Aug 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $535M | $47.7M | $559.2M | +578% |
| 2025 | $78.9M | $64.5M | $143.4M | −0% |
| 2024 | $79.2M | $19.5M | $105.7M | +358% |
| 2023 | $17.3M | $17.2M | $33.4M | −18% |
| 2022 | $21M | $14.4M | $79.8M | −69% |
| 2021 | $66.9M | $21.8M | $147.2M | +241% |
| 2020 | $19.7M | $18.9M | $43.1M | −15% |
| 2019 | $23M | $22.7M | $49.6M | n/a |
Against its peers
Companies in Biotechnology nearest Entera Bio's size, closest first, today.
| Company | Market cap |
|---|---|
| ENTXEntera Bio | $535M |
| MGTXMeiraGTx | $895.1M |
| PLXProtalix BioTherapeutics | $206.3M |
| VCELVericel | $2.1B |
| ADMAAdma Biologics | $2.5B |
| Peer median | $1.5B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Entera Bio
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.